89 related articles for article (PubMed ID: 7578406)
21. Gut epithelial cells as targets for gene therapy of hemophilia.
Lozier JN; Yankaskas JR; Ramsey WJ; Chen L; Berschneider H; Morgan RA
Hum Gene Ther; 1997 Aug; 8(12):1481-90. PubMed ID: 9287148
[TBL] [Abstract][Full Text] [Related]
22. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
23. Towards gene therapy for haemophilia B using primary human keratinocytes.
Gerrard AJ; Hudson DL; Brownlee GG; Watt FM
Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952
[TBL] [Abstract][Full Text] [Related]
24. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
[TBL] [Abstract][Full Text] [Related]
25. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
[TBL] [Abstract][Full Text] [Related]
26. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo fibroblast transduction in rabbits results in long-term (>600 days) factor IX expression in a small percentage of animals.
Chen L; Nelson DM; Zheng Z; Morgan RA
Hum Gene Ther; 1998 Nov; 9(16):2341-51. PubMed ID: 9829533
[TBL] [Abstract][Full Text] [Related]
28. Retroviral-mediated in vivo gene transfer into muscle cells and synthesis of human factor IX in mice.
Baru M; Sha'anani J; Nur I
Intervirology; 1995; 38(6):356-60. PubMed ID: 8880387
[TBL] [Abstract][Full Text] [Related]
29. Construction and its expression of a new retroviral vector containing a human blood coagulation factor IX cDNA.
Matsushita T; Emi N; Takahashi I; Takamatsu J; Saito H
Thromb Res; 1993 Feb; 69(4):387-93. PubMed ID: 8470060
[TBL] [Abstract][Full Text] [Related]
30. Long-term expression of human factor IX cDNA in rabbits.
Zhou JM; Qiu XF; Lu DR; Lu JY; Xue JL
Sci China B; 1993 Nov; 36(11):1333-41. PubMed ID: 8142022
[TBL] [Abstract][Full Text] [Related]
31. Expansion and fibronectin-enhanced retroviral transduction of primary human T lymphocytes for adoptive immunotherapy.
Stockschläder M; Haiss M; Exner S; Schmah O; Veelken H; Follo M; Rüger R; Finke J
J Hematother Stem Cell Res; 1999 Aug; 8(4):401-10. PubMed ID: 10634178
[TBL] [Abstract][Full Text] [Related]
32. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver.
Yao SN; Farjo A; Roessler BJ; Davidson BL; Kurachi K
Viral Immunol; 1996; 9(3):141-53. PubMed ID: 8890472
[TBL] [Abstract][Full Text] [Related]
34. The three in-frame ATG, clustered in the translation initiation sequence of human factor IX gene, are required for an optimal protein production.
Enjolras N; Rodriguez MH; Plantier JL; Maurice M; Attali O; Négrier C
Thromb Haemost; 1999 Oct; 82(4):1264-9. PubMed ID: 10544911
[TBL] [Abstract][Full Text] [Related]
35. [Splicing and stability of intron in the expression retroviral vector with human clotting factor IX].
Xing YN; Lu DR; Gao XB; Qiu XF; Xue JL
Yi Chuan Xue Bao; 1998 Dec; 25(6):471-7. PubMed ID: 10465892
[TBL] [Abstract][Full Text] [Related]
36. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
37. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
38. An ex vivo keratinocyte model for gene therapy of hemophilia B.
Page SM; Brownlee GG
J Invest Dermatol; 1997 Aug; 109(2):139-45. PubMed ID: 9242498
[TBL] [Abstract][Full Text] [Related]
39. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice.
Kim HS; Kim JC; Lee YK; Kim JS; Park YS
J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610
[TBL] [Abstract][Full Text] [Related]
40. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion.
Cherington V; Chiang GG; McGrath CA; Gaffney A; Galanopoulos T; Merrill W; Bizinkauskas CB; Hansen M; Sobolewski J; Levine PH; Greenberger JS; Hurwitz DR
Hum Gene Ther; 1998 Jul; 9(10):1397-407. PubMed ID: 9681411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
